The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
about
Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects.Effect of statin (HMG-Co-A-Reductase Inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes.Chemokines and atherosclerosis
P2860
The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
@ast
The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
@en
The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
@nl
type
label
The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
@ast
The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
@en
The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
@nl
prefLabel
The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
@ast
The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
@en
The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
@nl
P2860
P1476
The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11883-001-0073-0
P577
2001-09-01T00:00:00Z
P5875
P6179
1051256424